Leerink Partners analyst Thomas Smith reiterated a Buy rating on Viridian Therapeutics (VRDN – Research Report) on November 12 and set a ...

Axsome Therapeutics (AXSM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ami ...

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

In this photo illustration, Amgen logo is displayed on a smartphone with a S&P ... [+] index website background. (Photo ...

If the United States does not lead in emerging biotechnologies, our adversaries will, writes GOP Sen. Todd Young of Indiana.

Crescat Capital's latest research letter illustrates the historic countercyclicality of gold mining stocks vs. the broad US ...

Mirati Therapeutics is the subject of takeover speculation in the biopharma sector once again, as it waits for the FDA's decision on its KRAS inhibitor adagrasib in non-small cell lung cancer (NSCLC).

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Dyne Therapeutics Inc. 4.27% $2.94B ...

Showcase your company news with guaranteed exposure both in print and online Most Admired CEOs were built for times like these. Their leadership & actions are guiding the… 25 years ago, Denver's ...

Sanofi S.A. Part Cert 0.06% €8.19M ...